K
Khashayar Sakhaee
Researcher at University of Texas System
Publications - 11
Citations - 637
Khashayar Sakhaee is an academic researcher from University of Texas System. The author has contributed to research in topics: Citric acid & Calcium. The author has an hindex of 7, co-authored 11 publications receiving 609 citations. Previous affiliations of Khashayar Sakhaee include University of Texas Health Science Center at San Antonio & Northwestern University.
Papers
More filters
Journal ArticleDOI
Long-Term Treatment of Calcium Nephrolithiasis with Potassium Citrate
TL;DR: Physiological, physicochemical and clinical validation is provided for the use of potassium citrate in the treatment of hypocitraturic calcium nephrolithiasis and uric acid lithiasis with or without calcium ne phytochemicals, and in patients with relapse after other treatment, including thiazide.
Journal ArticleDOI
Successful management of uric acid nephrolithiasis with potassium citrate.
TL;DR: Five patients with uric acid nephrolithiasis showed different responses between sodium alkali and potassium alkali treatment, and all five patients had persistently low urinary pH and normouricosuria, and four had hyperuricemia.
Journal ArticleDOI
Assessment of the pathogenetic role of physical exercise in renal stone formation.
TL;DR: It is suggested that moderate physical exercise, without increased fluid intake to compensate for excessive sweating, may cause the crystallization of uric acid and calcium oxalate in urine and may enhance the risk of the formation of renal stones composed of these salts.
Journal ArticleDOI
Converting enzyme inhibition causes hypocitraturia independent of acidosis or hypokalemia
Joel Z. Melnick,Patricia A. Preisig,Patricia A. Preisig,Sharon Haynes,Sharon Haynes,Charles Y.C. Pak,Charles Y.C. Pak,Khashayar Sakhaee,Khashayar Sakhaee,Robert J. Alpern,Robert J. Alpern +10 more
TL;DR: Enalapril decreases urinary citrate in rats and humans and causes increases in cytosolic citrate metabolism through ATP citrate lyase in rats similar to that seen with chronic metabolic acidosis and hypokalemia.
Journal ArticleDOI
Attainment of therapeutic fluoride levels in serum without major side effects using a slow-release preparation of sodium fluoride in postmenopausal osteoporosis.
Charles Y.C. Pak,Khashayar Sakhaee,Christopher Gallagher,Carol Parcel,Roy D. Peterson,Joseph E. Zerwekh,Martha Lemke,Faye Britton,Ming‐Chue ‐C Hsu,Beverley V. Adams +9 more
TL;DR: Slow‐release sodium fluoride confers desired level of fluoride in serum, while providing safety of usage, while avoiding sharp peaks produced by a rapid‐release preparation.